Lojda Z
J Histochem Cytochem. 1981 Mar;29(3A Suppl):481-93. doi: 10.1177/29.3.481.
The usefulness of optimized and newly elaborated histochemical methods for proteinases is illustrated on two selected substances. DAP IV (Gly-Pro-MNA,FBB,pH 7.2) was discovered in 39% and DAP II (Lys-Ala-MNA,FBB,pH 5.5) in 60% of the lymphocytes of human peripheral blood (ly). The reaction product of such ly differs in quality and quantity. On the ultrastructural level, the reaction product of DAP IV (Gly-Pro-MNA,HNF) was found in cell membranes and lysosomes. Enzyme activity in other areas was probably suppressed during the preparation procedure. Although the number of ly revealed with Lys-Pro-MNA and Phe-Pro-MNA at pH 5.5 and with Lys-Pro-MNA at pH 7.2 is high, these substrates do not distinctly discriminate DAP IV and DAP II. DAP IV occurs exclusively in T lymphocytes. The number of DAP IV-positive ly was not decreased in patients with myelofibrosis, plasmacytoma, chronic granulocytic leukemia, or tricholeukemia. It was, however, greatly reduced in chronic lymphatic leukemia (CLL). In patients with malignant lymphomas other than CLL, ly presence is related to the stage of the disease. Decreased values indicate a more severe stage or a relapse. In the majority of patients with gastric cancer DAP IV-positive ly were decreased. They were normal or increased in patients with peptic ulcer. The assessment of the number of DAP IV-positive ly is a simple method that provides information regarding the condition of patients with malignant lymphomas and gastric carcinoma. Neutrophilic leukocytes and their precursors, and to a lesser extent monocytes, are revealed when N-acetyl-Met-I-naphthyl ester (Ac-Met-N) is used as substrate. Membrane-bound lysosomal and cytosol proteinases were investigated together with disaccharidases in jejunal biopsies of patients with malabsorption syndrome. Activities of all enzymes were affected in patients with celiac disease. According to their impairment enzymes could be arranged: Lactase(L). trehalase (T), brush border endopeptidase (BBEP), gamma-glutamyl transferase (GGT), DAP IV, enzyme(s) cleaving Ac-Mer-N, aminopeptidase A, cytosol peptidases and aminopeptidase M. In the propria, DAP IV is decreased or absent, while GGT and, particularly, DAP II are increased. After a gluten-free diet, activities are restored in a reverse order. BBEP and GGT are useful as auxiliary parameters in the assessment of the damage or differentiation degree of enterocytes. DAP IV is a sensitive indicator of the involvement of the propria.
两种特定物质展示了优化和新改进的蛋白酶组织化学方法的实用性。在人类外周血淋巴细胞中,39%发现了DAP IV(甘氨酰 - 脯氨酰 - MNA,FBB,pH 7.2),60%发现了DAP II(赖氨酰 - 丙氨酰 - MNA,FBB,pH 5.5)。此类淋巴细胞的反应产物在质量和数量上有所不同。在超微结构水平上,DAP IV(甘氨酰 - 脯氨酰 - MNA,HNF)的反应产物存在于细胞膜和溶酶体中。在制备过程中,其他区域的酶活性可能受到抑制。尽管在pH 5.5时用赖氨酰 - 脯氨酰 - MNA和苯丙氨酰 - 脯氨酰 - MNA以及在pH 7.2时用赖氨酰 - 脯氨酰 - MNA检测出的淋巴细胞数量很高,但这些底物并不能明显区分DAP IV和DAP II。DAP IV仅存在于T淋巴细胞中。骨髓纤维化、浆细胞瘤、慢性粒细胞白血病或毛发白血病患者中,DAP IV阳性淋巴细胞的数量并未减少。然而,在慢性淋巴细胞白血病(CLL)中其数量大幅减少。在非CLL的恶性淋巴瘤患者中,淋巴细胞的存在与疾病阶段相关。数值降低表明疾病处于更严重阶段或复发。在大多数胃癌患者中,DAP IV阳性淋巴细胞减少。消化性溃疡患者中其数量正常或增加。评估DAP IV阳性淋巴细胞的数量是一种简单方法,可提供有关恶性淋巴瘤和胃癌患者病情的信息。当使用N - 乙酰 - 甲硫氨酸 - I - 萘酯(Ac - Met - N)作为底物时,可检测到嗜中性白细胞及其前体,单核细胞的检测程度较低。在吸收不良综合征患者的空肠活检中,对膜结合的溶酶体和胞质蛋白酶以及双糖酶进行了研究。乳糜泻患者中所有酶的活性均受到影响。根据酶受损程度可排列如下:乳糖酶(L)、海藻糖酶(T)、刷状缘内肽酶(BBEP)、γ - 谷氨酰转移酶(GGT)、DAP IV、切割Ac - Mer - N的酶、氨肽酶A、胞质肽酶和氨肽酶M。在固有层中,DAP IV减少或缺失,而GGT,特别是DAP II增加。无麸质饮食后,活性以相反顺序恢复。BBEP和GGT作为辅助参数可用于评估肠细胞的损伤或分化程度。DAP IV是固有层受累的敏感指标。